Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

ORAGENICS, INC — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

ORAGENICS, INC

via GSP CONSULTING CORP

3rd Quarter (July 1 - Sep 30) · 2010Posted Oct 18, 2010Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: ORAGENICS, INC
Description: phamaceutical company
Location: Florida · United States of America

Registrant

Firm: GSP CONSULTING CORP
Description: Govermnent Affairs Constulting Firm
Location: Pittsburgh, Pennsylvania, United States of America

Lobbying activities

1 issue

Health Issues
Oral health advocacy
Lobbyistsmr AARON LOUIS GRAU · COLETTE MARCHESINI
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.